These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. dbPepNeo: a manually curated database for human tumor neoantigen peptides. Tan X; Li D; Huang P; Jian X; Wan H; Wang G; Li Y; Ouyang J; Lin Y; Xie L Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32090262 [TBL] [Abstract][Full Text] [Related]
46. Spliceogen: an integrative, scalable tool for the discovery of splice-altering variants. Monger S; Troup M; Ip E; Dunwoodie SL; Giannoulatou E Bioinformatics; 2019 Nov; 35(21):4405-4407. PubMed ID: 30993321 [TBL] [Abstract][Full Text] [Related]
47. Neoantigens in Hematologic Malignancies. Biernacki MA; Bleakley M Front Immunol; 2020; 11():121. PubMed ID: 32117272 [TBL] [Abstract][Full Text] [Related]
48. Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer. Afsari B; Guo T; Considine M; Florea L; Kagohara LT; Stein-O'Brien GL; Kelley D; Flam E; Zambo KD; Ha PK; Geman D; Ochs MF; Califano JA; Gaykalova DA; Favorov AV; Fertig EJ Bioinformatics; 2018 Jun; 34(11):1859-1867. PubMed ID: 29342249 [TBL] [Abstract][Full Text] [Related]
49. Main Strategies for the Identification of Neoantigens. Gopanenko AV; Kosobokova EN; Kosorukov VS Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036391 [TBL] [Abstract][Full Text] [Related]
50. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors. Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255 [TBL] [Abstract][Full Text] [Related]
51. Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma. Mørk SK; Kadivar M; Bol KF; Draghi A; Westergaard MCW; Skadborg SK; Overgaard N; Sørensen AB; Rasmussen IS; Andreasen LV; Yde CW; Trolle T; Garde C; Friis-Nielsen J; Nørgaard N; Christensen D; Kringelum JV; Donia M; Hadrup SR; Svane IM Oncoimmunology; 2022; 11(1):2023255. PubMed ID: 35036074 [TBL] [Abstract][Full Text] [Related]
52. Neoantigens in precision cancer immunotherapy: from identification to clinical applications. Zhang Q; Jia Q; Zhang J; Zhu B Chin Med J (Engl); 2022 Jun; 135(11):1285-1298. PubMed ID: 35838545 [TBL] [Abstract][Full Text] [Related]
53. Engineering neoantigen vaccines to improve cancer personalized immunotherapy. Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174 [TBL] [Abstract][Full Text] [Related]
54. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information. Kim S; Kim HS; Kim E; Lee MG; Shin EC; Paik S; Kim S Ann Oncol; 2018 Apr; 29(4):1030-1036. PubMed ID: 29360924 [TBL] [Abstract][Full Text] [Related]